Bernhard Gentner
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
- Hematology 20
- Acute Myeloid Leukemia Research 10
- Hematopoietic Stem Cell Transplantation 10
- Genetics 16
- Virus-based gene therapy research 16
- Glioma Diagnosis and Treatment 6
- Co-authors
- Luigi Naldini (46 shared papers)Mario Amendola (5 shared papers)Roberta Mazzieri (5 shared papers)Erika Zonari (8 shared papers)Davide Moi (3 shared papers)Brian D. Brown (2 shared papers)Ferdinando Pucci (3 shared papers)Alice Giustacchini (6 shared papers)
- Journals
- Blood (14 papers)Molecular Therapy (8 papers)Science Translational Medicine (4 papers)Annals of Oncology (4 papers)Cancer Cell (4 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Bernhard Gentner
94 papers receiving 5.5k citations
Bernhard Gentner's Hit Papers
Peers
Comparison fields: 5 of 68
- Hematology 731
- Cancer Research 541
- Developmental Neuroscience 77
- Immunology 508
- Oncology 573
Countries citing papers authored by Bernhard Gentner
This map shows the geographic impact of Bernhard Gentner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Gentner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Gentner more than expected).
Fields of papers citing papers by Bernhard Gentner
This network shows the impact of papers produced by Bernhard Gentner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Gentner. The network helps show where Bernhard Gentner may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernhard Gentner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 546 | |
| 2 | Targeted genome editing in human repopulating haematopoietic stem cells Hit paper breakdown → | 2014 | 486 |
| 3 | 2007 | 483 | |
| 4 | Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation Hit paper breakdown → | 2019 | 331 |
| 5 | 2013 | 322 | |
| 6 | 2008 | 269 | |
| 7 | 2016 | 223 | |
| 8 | 2010 | 185 | |
| 9 | 2012 | 177 | |
| 10 | 2012 | 169 | |
| 11 | 2003 | 165 | |
| 12 | 2022 | 146 | |
| 13 | 2023 | 146 | |
| 14 | 2017 | 134 | |
| 15 | 2013 | 128 | |
| 16 | 2013 | 110 | |
| 17 | 2014 | 101 | |
| 18 | 2018 | 93 | |
| 19 | 2009 | 78 | |
| 20 | 2017 | 72 |
About Bernhard Gentner
Bernhard Gentner is a scholar working on Hematology, Genetics, Oncology, Physiology and Genetics, having authored 103 papers that have together received 5.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), Lysosomal Storage Disorders Research (11 papers), Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (10 papers), CAR-T cell therapy research (9 papers), Glioma Diagnosis and Treatment (6 papers), CRISPR and Genetic Engineering (5 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Hematology (731 citations), Cancer Research (541 citations), Developmental Neuroscience (77 citations), Immunology (508 citations) and Oncology (573 citations). Bernhard Gentner has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Luigi Naldini, Mario Amendola, Roberta Mazzieri, Erika Zonari, Davide Moi, Brian D. Brown, Ferdinando Pucci, Alice Giustacchini, Anna Ranghetti and Letterio Salvatore Politi. Their work appears in journals such as Blood, Molecular Therapy, Science Translational Medicine, Annals of Oncology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.